通过分析皮肤磷酸化α-突触核蛋白识别从原发性震颤进展为帕金森病风险患者的研究 (Syn-T)
通过分析皮肤磷酸化α-突触核蛋白识别从原发性震颤进展为帕金森病风险患者
Background and Rationale Essential tremor (ET) affects over 6 million Americans and approximately 5% of adults over age 60. Patients with ET have a 10-20 times higher risk of developing Parkinson's disease (PD) compared to age-matched populations, with approximately 1% converting to PD annually. Post-mortem studies reveal Lewy body pathology in some ET patients, suggesting a subset may have prodromal PD. Current diagnostic tools (DaTscan, SYNTap) are either insufficiently sensitive for early disease, too expensive, or too invasive for routine screening. The Syn-One Test offers a minimally invasive approach to detect phosphorylated α-synuclein (P-SYN) pathology in skin biopsies.
Primary Objectives
- Identify which ET patients have P-SYN pathology indicative of prodromal PD
- Predict which patients are most likely to phenoconvert to PD
研究概览
地位
地位
条件
条件
研究类型
研究类型
注册 (估计的)
注册
联系人和位置
学习联系方式
学习联系方式
- 姓名:Jeannie Director of Clinical Research
- 电话号码:371 480-434-6446
- 邮箱:ClinicalResearch@cndlifesciences.com
学习地点
-
-
Arizona
-
Scottsdale、Arizona、美国、85258
- 招聘中
- Movement Disorders Center of Arizona
-
接触:
- Danica Evidente
- 电话号码:480-526-5441
- 邮箱:danica@movementdisorders.us
-
首席研究员:
- Virgilio Gerald H Evidente, MD
-
Scottsdale、Arizona、美国、85258
- 招聘中
- CND Clinical Research Center
-
接触:
- Jeannie Director of Clinical Research
- 电话号码:371 480-434-6446
- 邮箱:ClinicalResearch@cndlifesciences.com
-
首席研究员:
- Padma Mahant, MD
-
-
California
-
Irvine、California、美国、92617
- 尚未招聘
- University of California Irvine Health
-
接触:
- Shivani Venkateswaran
- 邮箱:shivanv1@uci.edu
-
首席研究员:
- Ann Ly, MD
-
副研究员:
- Niki Maki, MD
-
Los Angeles、California、美国、90048
- 尚未招聘
- Cedars-Sinai Medical Center
-
首席研究员:
- Michele Tagliati, MD
-
接触:
- Anne Tran
- 电话号码:310-423-1697
- 邮箱:anne.tran@cshs.org
-
接触:
- Michele Lima Gregorio, PhD
- 电话号码:424-315-0021
- 邮箱:michele.gregorio@cshs.org
-
-
Florida
-
Orlando、Florida、美国、32825
- 招聘中
- Neurology One
-
首席研究员:
- Ramon L Rodriguez, MD, FAAN
-
接触:
- Jinna Santiago, RN, CRC
- 电话号码:110 407-706-3060
- 邮箱:jsantiago@n1research.org
-
接触:
- Victor Lameda, CRC
- 电话号码:109 407-706-3060
- 邮箱:vlameda@n1research.org
-
-
Kansas
-
Kansas City、Kansas、美国、66160
- 招聘中
- University of Kansas Medical Center
-
副研究员:
- Kelly Lyons, PhD
-
接触:
- Kim Lee, Clinical Research Coordinator
- 电话号码:913-588-0013
- 邮箱:klee9@kumc.edu
-
首席研究员:
- Angela Richmond, MD
-
-
Kentucky
-
Louisville、Kentucky、美国、40202
- 招聘中
- Norton Healthcare
-
接触:
- Andrea J Gambrell, RN, BSN, CCM
- 电话号码:502-446-8544
- 邮箱:andrea.gambrell@nortonhealthcare.org
-
接触:
- Hannah Scully, RN
- 电话号码:502-588-0719
- 邮箱:hannah.scully@nortonhealthcare.org
-
首席研究员:
- Jason Crowell, MD
-
副研究员:
- Justin Phillips, MD
-
-
Michigan
-
Farmington Hills、Michigan、美国、48334
- 招聘中
- Quest Research Institute
-
接触:
- Denise Morgott
- 电话号码:248-957-8940
- 邮箱:denise.morgott@questri.com
-
首席研究员:
- Aaron Ellenbogen, DO
-
-
Tennessee
-
Memphis、Tennessee、美国、38157
- 招聘中
- Veracity Neurosciences LLC
-
接触:
- Hannah Touliatos
- 电话号码:901-443-9170
- 邮箱:hannah@veracityneuroscience.com
-
首席研究员:
- Mark LeDoux, MD, PhD
-
Nashville、Tennessee、美国、37232
- 招聘中
- Vanderbilt University Medical Center
-
接触:
- Jackie Harris, RMA, CTRC IV
- 电话号码:615-936-3833
- 邮箱:jacqueline.c.harris@vumc.org
-
接触:
- Keimora Wright, CTRC II
- 电话号码:615-322-0530
- 邮箱:keimora.wright@vumc.org
-
首席研究员:
- Cherrie Yu, MD
-
副研究员:
- Amanda Currie, MD
-
-
Texas
-
Houston、Texas、美国、77030
- 招聘中
- Baylor College of Medicine
-
接触:
- Haneyeh Primary Research Coordinator
- 电话号码:713-798-5120
- 邮箱:haneyeh.amidi@bcm.edu
-
接触:
- Rory Research Manager
- 电话号码:713-798-5989
- 邮箱:Rory.Mahabir@bcm.edu
-
首席研究员:
- Steven Bellows, MD
-
副研究员:
- Karim Makhoul, MD
-
副研究员:
- Yutong Taneff, NP
-
-
参与标准
资格标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Subjects will be enrolled from up to 18 sites across the US from academic institutions and private clinics.
描述
Inclusion Criteria:
- Age 50-85 years old
- Diagnosis of ET as defined by the 2018 MDS Task force paper "1) isolated tremor syndrome of bilateral upper limb action tremor 2) at least 3 years' duration 3) with or without tremor in other locations (e.g., head, voice, or lower limbs) 4) absence of other neurological signs, such as dystonia, ataxia, or parkinsonism." OR
- Diagnosis of ET-Plus as stated by the 2018 MDS Task force paper, "Tremor with the characteristics of ET and additional neurological signs of uncertain significance such as impaired tandem gait, questionable dystonic posturing, memory impairment, or other mild neurologic signs of unknown significance that do not suffice to make an additional syndrome classification or diagnosis. ET with tremor at rest should be classified here."
- Willing to participate in all study procedures
- Able and willing to provide written informed consent
Exclusion Criteria:
- Under age 50, Over age 85
- Clinical evidence of severe peripheral vascular disease
- Clinically active coronary artery or cerebrovascular disease
- Participant is currently on anticoagulant or dual anti-platelet therapy
- Alcoholism
- Allergic reaction to local anesthesia
- History of or increased risk for impaired wound healing, scarring, or keloid formation
- Diagnosis of ET or ET-Plus that is clinically determined to likely be secondary to brain injury or vascular compromise
- History of other neurodegenerative disorder or evidence of neurological co-pathology
- Abnormal DaTscan
- Participant is currently receiving treatment with carbidopa-levodopa for PD
- Isolated focal tremors (head, voice)
- Task-specific tremor (e.g., primary writing tremor)
- Position-specific tremors that does not otherwise meet clinical diagnostic criteria for ET
- Sudden onset and step-wise deterioration
- Prior to enrollment, receipt of an intracranial procedure intended to treat tremor or parkinsonism, including thalamic deep brain stimulation (DBS) implantation or focused ultrasound (FUS) thalamotomy. Other prior intracranial surgery is exclusionary only when, in the investigator's or Sponsor's Chief Medical Officer's judgment, it could materially affect motor assessments, diagnostic classification, participant safety, or interpretation of study outcomes.
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
团体/队列数
队列和干预
团体/队列团体/队列 |
|---|
|
Essential Tremor
Those diagnosed with Essential Tremor |
|
Essential Tremor Plus
Those diagnosed with Essential Tremor Plus |
研究衡量的是什么?
主要结果指标
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Quantity of P-SYN in skin
大体时间:From enrollment to completion of study participation from Baseline to Month 12 and then to Month 24
|
Quantity of P-SYN in biopsies as a biomarker for disease progression |
From enrollment to completion of study participation from Baseline to Month 12 and then to Month 24
|
|
Rate of Phenoconversion
大体时间:From enrollment to completion of study participation from Baseline to Month 12 and then to Month 24
|
Rate of phenoconversion from Essential Tremor to Parkinson's Disease over 24 months |
From enrollment to completion of study participation from Baseline to Month 12 and then to Month 24
|
合作者和调查者
合作者
合作者
研究记录日期
研究主要日期
学习开始 (实际的)
学习开始
初级完成 (估计的)
初级完成
研究完成 (估计的)
研究完成
研究注册日期
首次提交
首次提交
首先提交符合 QC 标准的
首先提交符合 QC 标准的
首次发布 (实际的)
首次发布
研究记录更新
最后更新发布 (实际的)
最后更新发布
上次提交的符合 QC 标准的更新
上次提交的符合 QC 标准的更新
最后验证
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.